drugset / Trial / NCT04561752

A Food Effect Study With ZN-c5 in Healthy Post-Menopausal Subjects

NCT04561752

Phase 1 Completed 20 enrolled Zeno Alpha Inc.
RandomizedCrossoverOpen-labelOther

Summary

This is a single-center, randomized, open-label, two-period, 2-way crossover food effect study to determine the comparative bioavailability of ZN-c5 under fed and fasting conditions, following single-dose administration of ZN-c5 capsules (150mg).

Timeline

Start
2020-11-02
Primary completion
2020-12-11
Completion
2020-12-16

Drugs

EvaluationDrugModalityDoseRoute
Subject ZN-c5 Unknown 150 mg

Indications

No indication recorded.